Announced Thu, 25 Jun · 17:53 IST
Trading Window Closure for Q1 FY27 Results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹76.40
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.8-0.1-0.5+1.4-1.7-4.1-10.7———
Up moveDown movePending
AI summary
Concord Drugs Ltd has announced closure of its trading window starting Wednesday, 01 July 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending 30 June 2026. During this period, Directors, Designated Employees, Insiders, and their immediate relatives are prohibited from trading in the company's securities. The Board Meeting date for approving the results will be announced separately.
Likely market impact
Routine SEBI compliance filing indicating upcoming quarterly results announcement. No direct impact on retail shareholders.